<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials
Image Overlay - Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

May 25, 2020

Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

Astrazeneca’s vaccine candidate has advanced to clinical trials with the prospect that it will be available by September. Yourway supports clinical trials to get them advanced to the clinic.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Media

Articles

Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Open chat
Come chat with us!
Hello! How can I help you?